We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
NAD+ Wellness Therapy · Physician-supervised
Physician-supervised NAD+ wellness therapy — designed to support cellular energy, mental clarity, and metabolic health as you age. Board-certified telehealth in all 50 states.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell of the human body. It is central to energy production, DNA repair, cellular signaling, and mitochondrial function — the biological infrastructure that keeps tissues resilient with age.
NAD+ levels decline naturally over time. Published data suggest tissue NAD+ can fall by roughly half by middle age, and this decline is associated with fatigue, slower cognitive processing, poor sleep quality, and accelerated cellular aging. Restoring NAD+ availability — through precursors like NMN and NR, or intravenous NAD+ — is one of the most actively studied areas in cellular longevity today.
NAD+ therapy is not a cure for aging. It is a physician-supervised intervention aimed at supporting healthy cellular function, based on emerging evidence.
The evidence base is emerging. Below is what current peer-reviewed studies and clinical trials support — framed cautiously, as the science demands.
Energy & vitality
NAD+ is essential for mitochondrial ATP production. Preclinical and early clinical studies suggest NAD+ restoration may support muscle function and reduce age-related fatigue. Larger human trials are ongoing.
Cognitive support
A small clinical study of NAD+ IV therapy in healthy adults reported improvements in cognitive performance measures. The proposed mechanism is enhanced mitochondrial energy production in neurons.
Sleep quality
A 2022 randomized study of NMN in older adults reported improved sleep efficiency and reduced daytime drowsiness — plausibly mediated by NAD+’s role in circadian rhythm regulation.
Metabolic health
A clinical trial in postmenopausal women with prediabetes reported improved insulin sensitivity after 10 weeks of oral NMN supplementation — an early but meaningful metabolic signal.
Cardiovascular support
Preliminary human studies of NAD+ precursors have reported improved endothelial function and reduced aortic stiffness. Evidence is early and further trials are required.
Inflammation
NAD+ participates in cellular pathways that regulate inflammation. Small studies have reported reductions in circulating inflammatory markers with NAD+ precursor supplementation.
Evidence note
The evidence for NAD+ therapy is emerging. Most human studies are small or short in duration. Large-scale randomized trials are still needed to confirm long-term benefits and risks. NAD+ therapy at kindr Health is physician-supervised and individualized. Results are not guaranteed, and NAD+ therapy is not a treatment for any disease.
Every protocol is designed and monitored by a board-certified physician. Here is what to expect.
01
Telehealth consultation with a board-certified kindr physician. Review of medical history, medications, symptoms, and goals. Optional baseline labs — fasting insulin, HbA1c, hsCRP, lipids — to establish a starting point.
02
Your physician selects the NAD+ precursor (NMN, NR, or niacin-based), dose, delivery method (oral or IV where available), and timeline — typically an 8–12 week initial protocol — based on your health profile and goals.
03
Structured check-ins at week 4 and week 8 review energy, sleep, and cognitive changes. A repeat metabolic panel evaluates objective biomarker response. Protocol adjustments are made based on tolerability and results.
04
NAD+ therapy is coordinated with HRT, peptide therapy, or GLP-1 metabolic care when clinically appropriate. All layers are supervised by the same kindr physician for safety and synergy.
NAD+ therapy is not a one-size-fits-all supplement. At kindr Health, every protocol is designed by a board-certified physician, based on your individual health profile and lab work, and continuously monitored for efficacy and side effects.
Potential side effects are usually mild and may include flushing (with niacin-based precursors), transient nausea or GI upset, headache, or dizziness at high IV doses. Your kindr physician adjusts precursor, dosing, and delivery method to minimize these effects.
Clinical content on this page is reviewed by the Kindr Health Editorial & Clinical Team (Organizational NPI 1609792902). Last reviewed 2026-07-18.
Transparent pricing. No insurance required. Package pricing includes physician oversight and monitoring.
$699
8-week protocol
$1,299
12-week protocol
$2,499
12-week protocol
NAD+ therapy involves supplementing with NAD+ or its precursors — NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside) — to support cellular energy production, DNA repair, and metabolic health. At kindr, it is delivered orally or, where available, via IV under board-certified physician supervision.
Individual response varies. Some patients report improved energy and sleep within 2–4 weeks. Metabolic and cognitive changes, when they occur, are typically evaluated at the 8–12 week lab recheck. Results are not guaranteed; the evidence for NAD+ therapy is emerging.
When prescribed and monitored by a qualified physician, NAD+ precursor therapy is generally well tolerated in published trials. Common side effects are mild and include flushing (with niacin-based forms), nausea, GI upset, or headache. Your kindr physician screens for contraindications and adjusts dose and delivery to minimize side effects.
Yes. NAD+ precursor therapy and hormone replacement therapy have no clinically significant interaction and can be coordinated by your kindr physician. HRT restores the hormonal baseline; NAD+ therapy targets downstream cellular energy and metabolic support.
Both NMN and NR are precursors the body converts into NAD+. NMN is one biosynthetic step closer to NAD+; NR has the longest human safety record and larger clinical trial dataset. Your kindr physician recommends the precursor, dose, and delivery method based on your health profile and goals.
Initial physician consultation is $199. Monthly protocols range from $299–$499 depending on delivery method (oral vs IV) and dosing. Insurance is not required. Full package pricing is reviewed during your consultation.
We recommend a baseline metabolic panel — fasting insulin, HbA1c, hsCRP, and a lipid panel — to assess metabolic status and personalize your protocol. Body composition analysis is optional and available where offered.
Small clinical studies suggest NAD+ may support cognitive performance through improved mitochondrial function. It is not a standalone treatment for brain fog. In perimenopausal or postmenopausal women, brain fog often has a hormonal driver and is best evaluated as part of a comprehensive plan that may include HRT and lifestyle optimization.
NAD+ precursors (NMN, NR) are regulated as dietary supplements in the United States, not as FDA-approved drugs. NAD+ IV therapy is administered off-label under physician supervision. kindr Health follows all applicable federal and state regulations and dispenses through licensed pharmacy partners.
NAD+ therapy is not recommended during pregnancy or breastfeeding, in individuals with uncontrolled cardiovascular or renal disease, or where medication interactions preclude safe use. Your kindr physician reviews your full medical history before any protocol is prescribed.
Restore hormonal baseline for perimenopause and menopause.
Tissue repair, recovery, and cognitive support peptides.
Integrated GLP-1 + HRT + cellular longevity care.
Understand your menopause stage and cellular readiness.
kindr Health actively tracks emerging research in cellular longevity — including senolytics, mitochondrial support compounds, and metabolic optimization. Our physicians integrate new evidence into personalized protocols as it becomes clinically actionable. Learn more about our Metabolic Menopause Protocol.
Book a consultation with a Kindr Health physician and discover whether NAD+ therapy fits your wellness goals.
Cardiovascular Health
After menopause, women's blood pressure catches up to — and often surpasses — men's. Yet hypertension in midlife women is underdiagnosed and undertreated. Here is what every woman over 45 should know.
Read The silent threat: why hypertension rises sharply in women after menopause →
Perimenopause
A new study shows ovaries display molecular signs of aging — inflammation, fibrosis, senescence — years before the final period. Here is why that changes how we should think about perimenopause care.
Symptoms
Frozen shoulder (adhesive capsulitis) is a painful, progressive loss of shoulder motion that peaks in women aged 40–60 — the same window as perimenopause. Declining estrogen appears to affect collagen, joint lubrication, and inflammation, which researchers believe may help explain the link.